ATE373502T1 - Carbostyril-derivative zur beschleunigten speichelabsonderung - Google Patents

Carbostyril-derivative zur beschleunigten speichelabsonderung

Info

Publication number
ATE373502T1
ATE373502T1 AT04747458T AT04747458T ATE373502T1 AT E373502 T1 ATE373502 T1 AT E373502T1 AT 04747458 T AT04747458 T AT 04747458T AT 04747458 T AT04747458 T AT 04747458T AT E373502 T1 ATE373502 T1 AT E373502T1
Authority
AT
Austria
Prior art keywords
carbostyril
saliva
accelerated
xerostomia
prophylaxis
Prior art date
Application number
AT04747458T
Other languages
English (en)
Inventor
Hisashi Nagamoto
Masayuki Kohashi
Hiroshi Oka
Original Assignee
Otsuka Pharma Co Ltd
Univ School St Marianna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Univ School St Marianna filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE373502T1 publication Critical patent/ATE373502T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT04747458T 2003-07-30 2004-07-07 Carbostyril-derivative zur beschleunigten speichelabsonderung ATE373502T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003282691 2003-07-30
JP2004021808 2004-01-29

Publications (1)

Publication Number Publication Date
ATE373502T1 true ATE373502T1 (de) 2007-10-15

Family

ID=34117911

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04747458T ATE373502T1 (de) 2003-07-30 2004-07-07 Carbostyril-derivative zur beschleunigten speichelabsonderung

Country Status (10)

Country Link
US (1) US7879877B2 (de)
EP (1) EP1648563B1 (de)
JP (1) JP4394686B2 (de)
KR (1) KR100681360B1 (de)
CN (1) CN1859948B (de)
AT (1) ATE373502T1 (de)
DE (1) DE602004009079T2 (de)
HK (1) HK1097474A1 (de)
MY (1) MY142739A (de)
WO (1) WO2005011811A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006112961A2 (en) 2005-03-03 2006-10-26 Takasago International Corp. (Usa) Synergistic salivation components
CN101910116B (zh) 2008-01-18 2013-06-19 高砂香料工业株式会社 (2e，6z，8e)-n-异丁基-2，6，8-癸三烯酰胺(千日菊酰胺)的制备方法，以及包含该化合物的食品或饮料、香料或化妆品、或药物
US8741930B2 (en) * 2008-10-24 2014-06-03 Bridge Pharma, Inc. Treating xerophthalmia with norketotifen
US9597278B2 (en) 2008-11-13 2017-03-21 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
US9884082B2 (en) 2008-11-13 2018-02-06 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
US8765787B2 (en) * 2008-11-21 2014-07-01 Bridge Pharma, Inc. Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen
CN103476753B (zh) 2011-02-25 2015-12-09 诺弗米克斯有限公司 新的瑞巴派特复合物和共晶体
MX2013010971A (es) * 2011-03-24 2013-10-07 Otsuka Pharma Co Ltd Una composicion farmaceutica para tratar una enfermedad en la cavidad oral que comprende rebamipida.
JP6710040B2 (ja) * 2015-11-06 2020-06-17 江崎グリコ株式会社 唾液分泌促進剤及び口腔用組成物
KR102190019B1 (ko) * 2018-10-23 2020-12-15 삼진제약주식회사 쇼그렌 증후군 예방 또는 치료용 조성물
EP4001434A3 (de) * 2020-11-18 2022-08-10 Korea Institute of Science and Technology Speichelbiomarker zur diagnose von xerostomie und seine verwendung

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322425A (en) * 1980-03-14 1982-03-30 Otsuka Pharmaceutical Co., Ltd. Compositions for treating glaucoma
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP2812998B2 (ja) 1989-08-14 1998-10-22 大塚製薬 株式会社 胃炎治療剤
WO1992021342A1 (en) * 1991-06-07 1992-12-10 Otsuka Pharmaceutical Co., Ltd. Antidiabetic
TW227558B (de) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
JP2872546B2 (ja) * 1992-11-26 1999-03-17 大塚製薬株式会社 腸粘膜障害保護剤
EP0641323A1 (de) 1993-03-18 1995-03-08 Otsuka Pharmaceutical Co., Ltd. Carbostyrilderivate als matrix-metallproteinaseinhibitoren
JP2839827B2 (ja) 1993-10-05 1998-12-16 大塚製薬株式会社 ウレアーゼ阻害剤
ATE184793T1 (de) 1993-10-21 1999-10-15 Otsuka Pharma Co Ltd Die verwendung von carbostyrilderivaten zur herstellung eines arzneimittels zur hemmung der produktion von interleukin-8
AU3191795A (en) 1994-08-10 1996-03-07 Otsuka Pharmaceutical Co., Ltd. Method of preventing and treating ophthalmic inflammation and/or wound
JPH0971532A (ja) 1995-09-06 1997-03-18 Otsuka Pharmaceut Co Ltd 発癌抑制剤
AR004214A1 (es) * 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
AU5410998A (en) 1996-12-16 1998-07-15 Otsuka Pharmaceutical Co., Ltd. Adp-ribosyltransferase inhibitor
JPH11228413A (ja) 1998-02-20 1999-08-24 Otsuka Pharmaceut Co Ltd Ｎａｄアーゼ阻害剤

Also Published As

Publication number Publication date
DE602004009079T2 (de) 2008-06-19
CN1859948B (zh) 2010-05-26
US20070112026A1 (en) 2007-05-17
EP1648563A1 (de) 2006-04-26
MY142739A (en) 2010-12-31
DE602004009079D1 (de) 2007-10-31
CN1859948A (zh) 2006-11-08
EP1648563B1 (de) 2007-09-19
WO2005011811A1 (en) 2005-02-10
HK1097474A1 (en) 2007-06-29
JP2006528662A (ja) 2006-12-21
KR20060037408A (ko) 2006-05-03
KR100681360B1 (ko) 2007-02-12
US7879877B2 (en) 2011-02-01
JP4394686B2 (ja) 2010-01-06

Similar Documents

Publication Publication Date Title
HK1097474A1 (en) Carbostyril derivatives for accelerating salivation
HUP0400636A2 (hu) Azetidinszármazékokat tartalmazó gyógyszerkészítmények, új azetidinszármazékok és előállításuk
NO20052739L (no) CCR5-antagonister som medikamenter
UA94901C2 (ru) Антибактериальные производные пиперидина
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
CY1111693T1 (el) Αντιιικοι παραγοντες
ATE397605T1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
BR0316771A (pt) Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica
NO20065075L (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer.
BR0210028A (pt) Agentes antibacterianos
BR0208741A (pt) Derivados de piperidina
ATE413388T1 (de) Muskarin antagonisten
NO20040881L (no) Orale antidiabetes midler.
TW200730176A (en) Formulations of quinolinones
ES2186550A1 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
MXPA04006041A (es) Antivirales de piridoquinoxalina.
GEP20084437B (en) Novel lincomycin derivatives possessing antimicrobial activity
CA2437785A1 (en) Hiv inhibiting pyrazinone derivatives
NO20044550L (no) Heterotrisyklyl 6-alkaliden-penemer som beta-laktamaseinhibitorer
EA200800152A1 (ru) Производные хинолина в качестве антибактериальных агентов
MXPA05010783A (es) Derivados antimicrobianos de [3.1.0] biciclohexilfenil-oxazolidinona y analogos.
AU2002248531A1 (en) Pyrazolopyriadine derivatives
BRPI0513549A (pt) composições farmacêuticas para o tratamento de leishmaniose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties